{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:29:15Z","timestamp":1789082955756,"version":"build-2803163510"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40265-025-02220-x","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:06:44Z","timestamp":1755241604000},"page":"1109-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Managing Burning Mouth Syndrome: Current and Future Directions"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-5594","authenticated-orcid":false,"given":"Linda","family":"Sangalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7807-0636","authenticated-orcid":false,"given":"Sahar","family":"Mirfarsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9828-8556","authenticated-orcid":false,"given":"Jill M.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elfatih","family":"Eisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-4604","authenticated-orcid":false,"given":"Craig S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"issue":"Suppl 1","key":"2220_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/odi.13067","volume":"25","author":"A Ariyawardana","year":"2019","unstructured":"Ariyawardana A, Chmieliauskaite M, Farag AM, Albuquerque R, Forssell H, Nasri-Heir C, Klasser GD, Sardella A, Mignogna MD, Ingram M, Carlson CR, Miller CS. World Workshop on Oral Medicine VII: burning mouth syndrome: a systematic review of disease definitions and diagnostic criteria utilized in randomized clinical trials. Oral Dis. 2019;25(Suppl 1):141\u201356.","journal-title":"Oral Dis"},{"key":"2220_CR2","unstructured":"International Headache Society. Burning mouth syndrome. 2018. Available from: http:\/\/ihs-classification.org\/en\/02\u2026\/04_teil3\/131805_facialpain.html Accessed 11 June 2025."},{"key":"2220_CR3","doi-asserted-by":"crossref","unstructured":"International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020;40:129\u2013221.","DOI":"10.1177\/0333102419893823"},{"key":"2220_CR4","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/odi.13868","volume":"28","author":"S Wu","year":"2022","unstructured":"Wu S, Zhang W, Yan J, Noma N, Young A, Yan Z. Worldwide prevalence estimates of burning mouth syndrome: a systematic review and meta-analysis. Oral Dis. 2022;28:1431\u201340.","journal-title":"Oral Dis"},{"key":"2220_CR5","first-page":"168","volume":"19","author":"MD Mignogna","year":"2005","unstructured":"Mignogna MD, Fedele S, Lo Russo L, Leuci S, Lo Muzio L. The diagnosis of burning mouth syndrome represents a challenge for clinicians. J Orofac Pain. 2005;19:168\u201373.","journal-title":"J Orofac Pain"},{"key":"2220_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/0972-4052.171823","volume":"15","author":"C Nasri-Heir","year":"2015","unstructured":"Nasri-Heir C, Zagury JG, Thomas D, Ananthan S. Burning mouth syndrome: current concepts. J Indian Prosthodont Soc. 2015;15:300\u20137.","journal-title":"J Indian Prosthodont Soc"},{"key":"2220_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3748\/wjg.v19.i5.665","volume":"19","author":"GE Gurvits","year":"2013","unstructured":"Gurvits GE, Tan A. Burning mouth syndrome. World J Gastroenterol. 2013;19:665\u201372.","journal-title":"World J Gastroenterol"},{"key":"2220_CR8","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1038\/s41598-023-33983-6","volume":"13","author":"HI Shin","year":"2023","unstructured":"Shin HI, Bang JI, Kim GJ, Kim MR, Sun G-II, Kim SY. Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions. Sci Rep. 2023;13:7257.","journal-title":"Sci Rep"},{"key":"2220_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.oooo.2022.12.015","volume":"136","author":"MV Rojas-Ramirez","year":"2023","unstructured":"Rojas-Ramirez MV, ElDomiaty W, Sangalli L, Al-Sabbah M, Dawson DR, Miller CS. Xerostomia, reduced salivary flow, and oral burning: associations from a cross-sectional study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;136:154\u201361.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2220_CR10","doi-asserted-by":"crossref","unstructured":"Sangalli L, ElDomiaty W, Miller CS. Xerogenic medications may contribute to decreased unstimulated salivary flow in patients with oral burning and\/or gastro-esophageal reflux disease. Front Dent Med. 2023;4:1047235.","DOI":"10.3389\/fdmed.2023.1047235"},{"key":"2220_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0333102416646769","volume":"37","author":"F Galli","year":"2017","unstructured":"Galli F, Lodi G, Sardella A, Vegni E. Role of psychological factors in burning mouth syndrome: a systematic review and meta-analysis. Cephalalgia. 2017;37:265\u201377.","journal-title":"Cephalalgia"},{"key":"2220_CR12","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/joor.13343","volume":"49","author":"F Canfora","year":"2022","unstructured":"Canfora F, Calabria E, Pecoraro G, D Aniello L, Aria M, Marenzi G, Sammartino P, Mignogna MD, Adamo D. The use of self-report questionnaires in an analysis of the multidimensional aspects of pain and a correlation with the psychological profile and quality of life in patients with burning mouth syndrome: a case\u2013control study. J Oral Rehab. 2022;49:890\u2013914.","journal-title":"J Oral Rehab"},{"key":"2220_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1515\/sjpain-2020-0047","volume":"20","author":"E Jedel","year":"2020","unstructured":"Jedel E, Elfstrom ML, H\u00e4gglin C. Health-related quality of life in burning mouth syndrome\u2014a case\u2013control study. Scand J Pain. 2020;20:829\u201336.","journal-title":"Scand J Pain"},{"key":"2220_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/08869634.2019.1681621","volume":"40","author":"GS Lee","year":"2022","unstructured":"Lee GS, Kim HK, Kim ME. Relevance of sleep, pain cognition, and psychological distress with regard to pain in patients with burning mouth syndrome. Cranio. 2022;40:79\u201387.","journal-title":"Cranio"},{"key":"2220_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.11607\/jop.1109","volume":"27","author":"D Adamo","year":"2013","unstructured":"Adamo D, Schiavone V, Aria M, Leuci S, Ruoppo E, Dell\u2019Aversana G, Mignogna MD. Sleep disturbance in patients with burning mouth syndrome: a case\u2013control study. J Orofac Pain. 2013;27:304\u201313.","journal-title":"J Orofac Pain"},{"key":"2220_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/odi.14051","volume":"29","author":"F Alhendi","year":"2023","unstructured":"Alhendi F, Ko E, Graham L, Corby P. The association of sleep disturbances with burning mouth syndrome: an overlooked relationship-a qualitative systematic review. Oral Dis. 2023;29:6\u201320.","journal-title":"Oral Dis"},{"key":"2220_CR17","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/odi.14553","volume":"30","author":"D Adamo","year":"2024","unstructured":"Adamo D, Calabria E, Canfora F, Coppola N, Pecoraro G, D\u2019Aniello L, Aria M, Mignogna MD, Leuci S. Burning mouth syndrome: analysis of diagnostic delay in 500 patients. Oral Dis. 2024;30:1543\u201354.","journal-title":"Oral Dis"},{"key":"2220_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.oooo.2019.09.015","volume":"129","author":"JE Freilich","year":"2020","unstructured":"Freilich JE, Kuten-Shorrer M, Treister NS, Woo SB, Villa A. Burning mouth syndrome: a diagnostic challenge. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129:120\u20134.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2220_CR19","first-page":"210","volume":"59","author":"GD Klasser","year":"2011","unstructured":"Klasser GD, Epstein JB, Villines D, Utsman R. Burning mouth syndrome: a challenge for dental practitioners and patients. Gen Dent. 2011;59:210\u201320.","journal-title":"Gen Dent"},{"key":"2220_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/03331024211036152","volume":"42","author":"HL Tan","year":"2022","unstructured":"Tan HL, Smith JG, Hoffmann J, Renton T. A systematic review of treatment for patients with burning mouth syndrome. Cephalalgia. 2022;42:128\u201361.","journal-title":"Cephalalgia"},{"key":"2220_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/jop.13641","volume":"54","author":"D Adamo","year":"2025","unstructured":"Adamo D. Burning mouth syndrome: unlocking the future of pharmacological treatment. J Oral Pathol Med. 2025;54:241\u201362.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cden.2022.07.004","volume":"67","author":"SN Khawaja","year":"2023","unstructured":"Khawaja SN, Alaswaiti OF, Scrivani SJ. Burning mouth syndrome. Dent Clin North Am. 2023;67:49\u201360.","journal-title":"Dent Clin North Am"},{"issue":"3","key":"2220_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/odi.12660","volume":"24","author":"YF Liu","year":"2018","unstructured":"Liu YF, Kim Y, Yoo T, Han P, Inman JC. Burning mouth syndrome: a systematic review of treatments. Oral Dis. 2018;24(3):325\u201334.","journal-title":"Oral Dis"},{"key":"2220_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.archger.2011.10.001","volume":"55","author":"JY Ko","year":"2012","unstructured":"Ko JY, Kim MJ, Lee SG, Kho HS. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS). Arch Gerontol Geriatr. 2012;55:755\u201361.","journal-title":"Arch Gerontol Geriatr"},{"issue":"11","key":"2220_CR25","volume":"11","author":"R McMillan","year":"2016","unstructured":"McMillan R, Forssell H, Buchanan JA, Glenny AM, Weldon JC, Zakrzewska JM. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev. 2016;11(11): CD002779.","journal-title":"Cochrane Database Syst Rev"},{"key":"2220_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.clinph.2011.07.054","volume":"123","author":"SK J\u00e4\u00e4skel\u00e4inen","year":"2012","unstructured":"J\u00e4\u00e4skel\u00e4inen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophys. 2012;123:71\u20137.","journal-title":"Clin Neurophys"},{"key":"2220_CR27","doi-asserted-by":"publisher","first-page":"11442","DOI":"10.3390\/ijms252111442","volume":"25","author":"M Kouri","year":"2024","unstructured":"Kouri M, Adamo D, Vardas E, Georgaki M, Canfora F, Mignogna MD, Nikitakis N. Small fiber neuropathy in burning mouth syndrome: a systematic review. INt J Mol Sci. 2024;25:11442.","journal-title":"INt J Mol Sci"},{"key":"2220_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.pain.2014.01.020","volume":"155","author":"Y Boucher","year":"2014","unstructured":"Boucher Y, Simons CT, Carstens MI, Carstens E. Effects of gustatory nerve transection and\/or ovariectomy on oral capsaicin avoidance in rats. Pain. 2014;155:814\u201320.","journal-title":"Pain"},{"key":"2220_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1155\/2003\/654735","volume":"8","author":"M Grushka","year":"2003","unstructured":"Grushka M, Epstein JB. Burning mouth syndrome and other oral sensory disorders: a unifying hypothesis. Pain Res Manag. 2003;8:133\u20135.","journal-title":"Pain Res Manag"},{"key":"2220_CR30","doi-asserted-by":"publisher","first-page":"628","DOI":"10.14219\/jada.archive.2007.0234","volume":"138","author":"E Eliav","year":"2007","unstructured":"Eliav E, Kamran B, Schaham R, Czerninski R, Gracely RH, Benoliel R. Evidence of chorda tympani dysfunction in patients with burning mouth syndrome. J Am Dent Assoc. 2007;138:628\u201333.","journal-title":"J Am Dent Assoc"},{"key":"2220_CR31","first-page":"202","volume":"23","author":"A Woda","year":"2009","unstructured":"Woda A, Dato T, Gremeau-Richard C. Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain. 2009;23:202\u201310.","journal-title":"J Orofac Pain"},{"key":"2220_CR32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joor.12795","volume":"46","author":"Y Imamura","year":"2019","unstructured":"Imamura Y, Shinozaki T, Okada-Ogawa A, Noma N, Shinoda M, Iwata K, Wada A, Abe O, Wang K, Svensson P. An updated review on pathophysiology and management of burning mouth syndrome with endocrinological, psychological and neuropathic perspectives. J Oral Rehab. 2019;46:574\u201387.","journal-title":"J Oral Rehab"},{"key":"2220_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.yfrne.2014.06.001","volume":"36","author":"BG Gunn","year":"2015","unstructured":"Gunn BG, Cunningham L, Mitchell SG, Swinny JD, Lambert JJ, Belelli D. GABA-A receptor-acting neurosteroids: a role in the development and regulation of the stress response. Front Neuroendocrinol. 2015;36:28\u201348.","journal-title":"Front Neuroendocrinol"},{"key":"2220_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pain.2006.01.020","volume":"122","author":"RJC Albuquerque","year":"2006","unstructured":"Albuquerque RJC, de Leeuw R, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain. 2006;122:223\u201334.","journal-title":"Pain"},{"key":"2220_CR35","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1177\/0333102419854052","volume":"39","author":"J Kishore","year":"2019","unstructured":"Kishore J, Shaikh F, Mirza S, Raffat MA, Ikram S, Akram Z. Cytokine levels and their role in the etiopathogenesis of burning mouth syndrome: a systematic review. Cephalalgia. 2019;39:1586\u201394.","journal-title":"Cephalalgia"},{"key":"2220_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.pain.2005.03.028","volume":"115","author":"GMA Lauria","year":"2005","unstructured":"Lauria GMA, Borgna M, Lombardi R, Penza P, Padovani A, Sapelli P. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain. 2005;115:332\u20137.","journal-title":"Pain"},{"key":"2220_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.adaj.2023.08.014","volume":"155","author":"S Heiliczer","year":"2024","unstructured":"Heiliczer S, Yanko R, Sharav Y, Aframian DJ, Klutstein M, Wilensky A, Haviv Y. Oxidative stress-mediated proapoptosis signaling: a novel theory on the mechanism underlying the pathogenesis of burning mouth syndrome. J Am Dent Assoc. 2024;155:258\u201367.","journal-title":"J Am Dent Assoc"},{"key":"2220_CR38","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/ijd.13634","volume":"56","author":"CS Morr Verenzuela","year":"2017","unstructured":"Morr Verenzuela CS, Davis MDP, Bruce AJ, Torgerson RR. Burning mouth syndrome: results of screening tests for vitamin and mineral deficiencies, thyroid hormone, and glucose levels-experience at Mayo Clinic over a decade. Int J Dermatol. 2017;56:952\u20136.","journal-title":"Int J Dermatol"},{"key":"2220_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030564","volume":"11","author":"C Sandoval","year":"2022","unstructured":"Sandoval C, Farias J, Zamorano M, Herrera C. Vitamin supplements as a nutritional strategy against chronic alcohol consumption? An updated review. Antioxidants. 2022;11: 564.","journal-title":"Antioxidants"},{"key":"2220_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/nu17050741","volume":"17","author":"C Reytor-Gonz\u00e1lez","year":"2025","unstructured":"Reytor-Gonz\u00e1lez C, Frias-Toral E, Nu\u00f1ez-V\u00e1squez C, Parise-Vasco JM, Zambrano-Villacres R, Simancas-Racines D, Schiavo L. Preventing and managing pre- and postoperative micronutrient deficiencies: a vital component of long-term success in bariatric surgery. Nutrients. 2025;17:741.","journal-title":"Nutrients"},{"key":"2220_CR41","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1111\/ene.14786","volume":"28","author":"J Stein","year":"2021","unstructured":"Stein J, Geisel J, Obeid R. Association between neuropathy and B-vitamins: a systematic review and meta-analysis. Eur J Neurol. 2021;28:2054\u201364.","journal-title":"Eur J Neurol"},{"key":"2220_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.13207","volume":"26","author":"CA Calder\u00f3n-Ospina","year":"2020","unstructured":"Calder\u00f3n-Ospina CA, Nava-Mesa MB. Vitamins in the nervous system: current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther. 2020;26:5\u201313.","journal-title":"CNS Neurosci Ther"},{"key":"2220_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","volume":"31","author":"KY Forrest","year":"2011","unstructured":"Forrest KY, Stuhidreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31:48\u201354.","journal-title":"Nutr Res"},{"key":"2220_CR44","doi-asserted-by":"publisher","unstructured":"Castillo LF, Pelletier CM, Heyden KE, Field MS. New insights into folate\u2013vitamin B12 interactions. Annu Rev Nutr. 2025; https:\/\/doi.org\/10.1146\/annurev-nutr-120524-043056. Epub ahead of\nprint. PMID: 40315282.","DOI":"10.1146\/annurev-nutr-120524-043056"},{"key":"2220_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jfma.2012.02.022","volume":"112","author":"HP Lin","year":"2013","unstructured":"Lin HP, Wang YP, Chen HM, Kuo YS, Lang MJ, Sun A. Significant association of hematinic deficiencies and high blood homocysteine levels with burning mouth syndrome. J Formos Med Assoc. 2013;112:319\u201325.","journal-title":"J Formos Med Assoc"},{"issue":"5S Suppl","key":"2220_CR46","doi-asserted-by":"publisher","first-page":"1500S","DOI":"10.1093\/jn\/130.5.1500S","volume":"130","author":"RS MacDonal","year":"2000","unstructured":"MacDonal RS. The role of zinc in growth and cell proliferation. J Nutr. 2000;130(5S Suppl):1500S-S1508.","journal-title":"J Nutr"},{"key":"2220_CR47","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1600-0714.2010.00914.x","volume":"39","author":"GS Cho","year":"2010","unstructured":"Cho GS, Han MW, Lee B, Roh JL, Choi SH, Cho KJ, Nam SY, Kim SY. Zinc deficiency may be a cause of burning mouth syndrome as zinc replacement therapy has therapeutic effects. J Oral Pathol Med. 2010;39:722\u20137.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jebdp.2011.09.016","volume":"11","author":"V Bhoopathi","year":"2011","unstructured":"Bhoopathi V, Mascarenhas AK. Zinc-replacement therapy may not reduce oral pain in patients with zinc-deficient burning mouth syndrome (BMS). J Evid Based Dent Pract. 2011;11:189\u201390.","journal-title":"J Evid Based Dent Pract"},{"key":"2220_CR49","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1600-0714.2006.00438.x","volume":"35","author":"A Sardella","year":"2006","unstructured":"Sardella A, Lodi G, Demarosi F, Uglietti D, Carrassi A. Causative or precipitating aspects of burning mouth syndrome: a case\u2013control study. J Oral Pathol Med. 2006;35:466\u201371.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR50","unstructured":"Borgnakke WS, Genco RJ, Eke PI, Taylor GW. Oral Health and Diabetes. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE. Diabetes in America, Chapter 31, 3rd edn. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018."},{"key":"2220_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jdiacomp.2006.08.001","volume":"21","author":"PA Moore","year":"2007","unstructured":"Moore PA, Guggnheimer J, Orchard T. Burning mouth syndrome and peripheral neuropathy in patients with type 1 diabetes mellitus. J Diabetes Complicat. 2007;21:397\u2013402.","journal-title":"J Diabetes Complicat"},{"key":"2220_CR52","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/j.tripleo.2007.07.030","volume":"105","author":"F Femiano","year":"2008","unstructured":"Femiano F, Lanza A, Buonaiuto C, Gombos F, Nunziata M, Cuccurullo L, Cirillo N. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:e22\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2220_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/amhsr.amhsr_39_16","volume":"6","author":"N Gupta","year":"2016","unstructured":"Gupta N, Arora M, Sharma R, Arora KS. Peripheral and central nervous system involvement in recently diagnosed cases of hypothyroidism: an electrophysiological study. Ann Med Health Sci Res. 2016;6:261\u20136.","journal-title":"Ann Med Health Sci Res"},{"issue":"83","key":"2220_CR54","first-page":"40","volume":"2020","author":"RJ Genco","year":"2000","unstructured":"Genco RJ, Borgnakke WS. Diabetes as a potential risk for periodontitis: association studies. Periodontol. 2000;2020(83):40\u20135.","journal-title":"Periodontol"},{"key":"2220_CR55","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jds.2023.01.009","volume":"18","author":"YH Wu","year":"2023","unstructured":"Wu YH, Chiang CP. Association of medications with burning mouth syndrome in Taiwanese aged patients. J Dent Sci. 2023;18:833\u20139.","journal-title":"J Dent Sci"},{"key":"2220_CR56","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/odi.13116","volume":"25","author":"L Azzi","year":"2019","unstructured":"Azzi L, Veronesi G, Tagliabue A, Croveri F, Maurino V, Reguzzoni M, Tettamanti L, Protasoni M, Spadari F. Is there an association between drugs and burning mouth syndrome? A case\u2013control study. Oral Dis. 2019;25:1634\u201344.","journal-title":"Oral Dis"},{"key":"2220_CR57","volume":"12","author":"T Obara","year":"2020","unstructured":"Obara T, Naito H, Nojima T, Koga H, Nakao A. Burning mouth syndrome induced by angiotensin-converting enzyme inhibitors. Cureus. 2020;12: e11376.","journal-title":"Cureus"},{"key":"2220_CR58","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.pain.2014.04.022","volume":"155","author":"SA Khan","year":"2014","unstructured":"Khan SA, Kaeser ML, Meiller TF, Seminowicz DA. Altered structure and function in the hippocampus and medial prefrontal cortex in patients with burning mouth syndrome. Pain. 2014;155:1472\u201380.","journal-title":"Pain"},{"key":"2220_CR59","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/ijcp.12626","volume":"69","author":"R Ye","year":"2015","unstructured":"Ye R, Hu Y, Yao A, Yang Y, Shi Y, Jiang Y, Zhang J. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer\u2019s disease: a meta-analysis. Int J Clin Pract. 2015;69:674\u201381.","journal-title":"Int J Clin Pract"},{"key":"2220_CR60","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jamapsychiatry.2017.0984","volume":"74","author":"MJM van Agtmaal","year":"2017","unstructured":"van Agtmaal MJM, Houben AJHM, Pouwer F, Stehouwer CDA, Schram MT. Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis. JAMA Psychiat. 2017;74:729\u201339.","journal-title":"JAMA Psychiat"},{"key":"2220_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15403\/jgld-2952","volume":"30","author":"F Di Mario","year":"2021","unstructured":"Di Mario F, Crafa P, Franceschi M, Rodriguez-Castro K, Baldassarre G, Ferronato A, Antico A, Panozzo MP, Franzoni L, Barchi A, Russo M, De Bortoli N, Ghisa M, Savarino E. Low levels of gastrin 17 are related with endoscopic findings of esophagitis and typical symptoms of GERD. J Gastrointestin Liver Dis. 2021;30:25\u20139.","journal-title":"J Gastrointestin Liver Dis"},{"key":"2220_CR62","volume":"93","author":"M Russo","year":"2022","unstructured":"Russo M, Crafa P, Franceschi M, Rodriguez-Castro KI, Franzoni L, Guglielmetti S, Fiore W, Di Mario F. Burning mouth syndrome and reflux disease: relationship and clinical implications. Acta Biomed. 2022;93: e2022329.","journal-title":"Acta Biomed"},{"key":"2220_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tripleo.2004.01.021","volume":"99","author":"PJ Lamey","year":"2005","unstructured":"Lamey PJ, Freeman R, Eddie SA, Pankhurst C, Rees T. Vulnerability and presenting symptoms in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:48\u201354.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2220_CR64","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00784-010-0419-5","volume":"15","author":"FO Netto","year":"2011","unstructured":"Netto FO, Diniz IM, Grossmann SM, de Abreu MH, do Carmo MA, Aguiar MC. Risk factors in burning mouth syndrome: a case\u2013control study based on patient records. Clin Oral Investig. 2011;15:571\u20135.","journal-title":"Clin Oral Investig"},{"key":"2220_CR65","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.archoralbio.2013.04.004","volume":"58","author":"MR Payeras","year":"2013","unstructured":"Payeras MR, Cherubini K, Figueiredo MA, Salum FG. Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol. 2013;58:1057\u201369.","journal-title":"Arch Oral Biol"},{"key":"2220_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00403-016-1667-2","volume":"308","author":"MS Alrashdan","year":"2016","unstructured":"Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016;308:539\u201351.","journal-title":"Arch Dermatol Res"},{"key":"2220_CR67","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.3390\/jcm13175280","volume":"13","author":"HY Nukaly","year":"2024","unstructured":"Nukaly HY, Halawani IR, Alghamdi SMS, Alruwaili AG, Binhezaim A, Algahamdi RAA, Alzahrani RAJ, Alharamlah FSS, Aldumkh SHS, Alasqah HMA, Alamri A, Jfri A. Oral lichen planus: a narrative review navigating etiologies, clinical manifestations, diagnostics, and therapeutic approaches. J Clin Med. 2024;13:5280.","journal-title":"J Clin Med"},{"key":"2220_CR68","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cden.2013.07.002","volume":"57","author":"BC Muzyka","year":"2013","unstructured":"Muzyka BC, Epifanio RN. Update on oral fungal infections. Dent Clin North Am. 2013;57:561\u201381.","journal-title":"Dent Clin North Am"},{"key":"2220_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cden.2023.07.007","volume":"68","author":"J Thakkar","year":"2024","unstructured":"Thakkar J, Dym H. Management of burning mouth syndrome. Dent Clin North Am. 2024;68:113\u20139.","journal-title":"Dent Clin North Am"},{"key":"2220_CR70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1601-0825.2009.01515.x","volume":"15","author":"R Marino","year":"2009","unstructured":"Marino R, Capaccio P, Pignataro L, Spadari F. Burning mouth syndrome: the role of contact hypersensitivity. Oral Dis. 2009;15:255\u20138.","journal-title":"Oral Dis"},{"key":"2220_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaad.2007.04.017","volume":"57","author":"RR Torgerson","year":"2007","unstructured":"Torgerson RR, Davis MD, Bruce AJ, Farmer SA, Rogers RS 3rd. Contact allergy in oral disease. J Am Acad Dermatol. 2007;57:315\u201321.","journal-title":"J Am Acad Dermatol"},{"key":"2220_CR72","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2340\/0001555576158159","volume":"76","author":"C Levanti","year":"1996","unstructured":"Levanti C, Ricciardi L, Isola S, Cilia M, Guarneri F, Purello D\u2019Ambrosio F. Burning mouth syndrome: hypersensitivity to sodium metabisulfite. Acta Derm Venereol. 1996;76:158\u20139.","journal-title":"Acta Derm Venereol"},{"key":"2220_CR73","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/cod.13267","volume":"81","author":"A S\u00e1nchez-Herrero","year":"2019","unstructured":"S\u00e1nchez-Herrero A, Vergara-de Caso E, Vera-\u00c1lvarez S, Espinosa-Hidalgo I, Silvestre Salvador JF. Burning mouth syndrome triggered by cinnamal present in a denture fixative cream. Contact Dermatitis. 2019;81:147\u20139.","journal-title":"Contact Dermatitis"},{"key":"2220_CR74","doi-asserted-by":"publisher","first-page":"867","DOI":"10.14219\/jada.2014.44","volume":"145","author":"JM Plemons","year":"2014","unstructured":"Plemons JM, Al-Hashimi I, Marek CL, American Dental Association Council on Scientific Affairs. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2014;145:867\u201373.","journal-title":"J Am Dent Assoc"},{"key":"2220_CR75","doi-asserted-by":"publisher","unstructured":"Molek M, Florenly F, Lister INE, Wahab TA, Lister C, Fioni F. Xerostomia and hyposalivation in association with oral candidiasis: a systematic review and meta-analysis. Evid Based Dent. 2022; https:\/\/doi.org\/10.1038\/s41432-021-0210-2. Epub ahead of print. PMID: 35075251.","DOI":"10.1038\/s41432-021-0210-2"},{"key":"2220_CR76","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.oooo.2012.05.009","volume":"114","author":"SM Osailan","year":"2012","unstructured":"Osailan SM, Pramanik R, Shirlaw P, Proctor GB, Challacombe SJ. Clinical assessment of oral dryness: development of a scoring system related to salivary flow and mucosal wetness. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:597\u2013603.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2220_CR77","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/00220345221130025","volume":"102","author":"R Alvarenga-Brant","year":"2023","unstructured":"Alvarenga-Brant R, Costa F, Mattos-Pereira G, Esteves-Lima RP, Bel\u00e9m FV, Lai H, Ge L, Gomez RS, Martins CC. Treatments for burning mouth syndrome: a network meta-analysis. J Dent Res. 2023;102:135\u201345.","journal-title":"J Dent Res"},{"key":"2220_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/sj.ebd.6401244","volume":"18","author":"DK Fischoff","year":"2017","unstructured":"Fischoff DK, Spivakovsky S. Little evidence to support or refute interventions for the management of burning mouth syndrome. Evid Based Dent. 2017;18:57\u20138.","journal-title":"Evid Based Dent"},{"key":"2220_CR79","doi-asserted-by":"publisher","first-page":"257","DOI":"10.11607\/ofph.1754","volume":"31","author":"M Kuten-Shorrer","year":"2017","unstructured":"Kuten-Shorrer M, Treister N, Stock S, Kelley JM, Ji YD, Woo SB, Lerman MA, Palmason S, Sonis ST, Villa A. Topical clonazepam solution for the management of burning mouth syndrome: a retrospective study. J Oral Facial Pain Headache. 2017;31:257\u201363.","journal-title":"J Oral Facial Pain Headache"},{"key":"2220_CR80","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/odi.12422","volume":"22","author":"Y Cui","year":"2016","unstructured":"Cui Y, Xu H, Chen FM, Liu JL, Jiang L, Zhou Y, Chen QM. Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis. Oral Dis. 2016;22:503\u201311.","journal-title":"Oral Dis"},{"key":"2220_CR81","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.oooo.2017.05.470","volume":"124","author":"M Kuten-Shorrer","year":"2017","unstructured":"Kuten-Shorrer M, Treister N, Stock S, Kelley JM, Ji YD, Woo SB, Lerman MA, Palmason S, Sonis ST, Villa A. Safety and tolerability of topical clonazepam solution for management of oral dysesthesia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124:146\u201351.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2220_CR82","first-page":"125","volume":"25","author":"K Amos","year":"2011","unstructured":"Amos K, Yeoh SC, Farah CS. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study. J Orofac Pain. 2011;25:125\u201330.","journal-title":"J Orofac Pain"},{"key":"2220_CR83","unstructured":"Basit H, Kahwaji CI. Clonazepam. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK556010\/ Accessed 14 June 2025."},{"key":"2220_CR84","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/lary.22490","volume":"122","author":"SM Heckmann","year":"2012","unstructured":"Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope. 2012;122:813\u20136.","journal-title":"Laryngoscope"},{"key":"2220_CR85","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jocn.2006.09.002","volume":"14","author":"Z Yilmaz","year":"2007","unstructured":"Yilmaz Z, Renton T, Yiangou Y, Zakrzewska J, Chessell I, Bountra C, Anand P. Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci. 2007;14:864\u201371.","journal-title":"J Clin Neurosci"},{"key":"2220_CR86","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/00016357.2016.1269191","volume":"75","author":"MR J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen MR, Pedersen AM. Analgesic effect of topical oral capsaicin gel in burning mouth syndrome. Acta Odontol Scand. 2017;75:130\u20136.","journal-title":"Acta Odontol Scand"},{"key":"2220_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104545","volume":"131","author":"R Singh","year":"2019","unstructured":"Singh R, Bansal Y, Parhar I, Kuhad A, Soga T. Neuropsychiatric implications of transient receptor potential vanilloid (TRPV) channels in the reward system. Neurochem Int. 2019;131: 104545.","journal-title":"Neurochem Int"},{"key":"2220_CR88","first-page":"2531","volume":"44","author":"TF Burks","year":"1985","unstructured":"Burks TF, Buck SH, Miller MS. Mechanisms of depletion of substance P by capsaicin. Fed Proc. 1985;44:2531\u20134.","journal-title":"Fed Proc"},{"key":"2220_CR89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5125\/jkaoms.2024.50.2.63","volume":"50","author":"SP Tirupathi","year":"2024","unstructured":"Tirupathi SP, Malothy S, Allaparthi U, Velvaluri S, Afnan L, Budia S, Sachdev M. Burning measure for burning mouth syndrome: a systematic review. J Korean Assoc Oral Maxillofac Surg. 2024;50:63\u20139.","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"2220_CR90","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1600-0714.2004.0194n.x","volume":"33","author":"M Petruzzi","year":"2004","unstructured":"Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J Oral Pathol Med. 2004;33:111\u20134.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR91","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12272-013-0057-y","volume":"36","author":"A Kukkar","year":"2013","unstructured":"Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013;36:237\u201351.","journal-title":"Arch Pharm Res"},{"key":"2220_CR92","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/pharmaceutics13040450","volume":"13","author":"M Kocot-K\u0119pska","year":"2021","unstructured":"Kocot-K\u0119pska M, Zaj\u0105czkowska R, Mika J, Kopsky DJ, Wordliczek J, Dobrogowski J, Przeklasa-Muszy\u0144ska A. Topical treatments and their molecular\/cellular mechanisms in patients with peripheral neuropathic pain\u2014narrative review. Pharmaceutics. 2021;13:450.","journal-title":"Pharmaceutics"},{"key":"2220_CR93","doi-asserted-by":"publisher","first-page":"e635","DOI":"10.4317\/medoral.16942","volume":"16","author":"E L\u00f3pez-D'alessandro","year":"2011","unstructured":"L\u00f3pez-D\u2019alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of burning mouth syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal. 2011;16:e635\u201340.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2220_CR94","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14476\/jomp.2014.39.3.96","volume":"39","author":"JY Heo","year":"2014","unstructured":"Heo JY, Ok SM, Jeong SH, Kim KH, Ahn YW. The effects of gabapentin in treatment of burning mouth syndrome: retrospective pilot study. J Oral Med Pain. 2014;39:96\u20139.","journal-title":"J Oral Med Pain"},{"key":"2220_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295559","volume":"18","author":"A Gramacy","year":"2023","unstructured":"Gramacy A, Villa A. Topical gabapentin solution for the management of burning mouth syndrome: a retrospective study. PLoS ONE. 2023;18: e0295559.","journal-title":"PLoS ONE"},{"key":"2220_CR96","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/add.13324","volume":"111","author":"RV Smith","year":"2016","unstructured":"Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016;111:1160\u201374.","journal-title":"Addiction"},{"key":"2220_CR97","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5152\/etd.2018.17160","volume":"40","author":"SL \u00c7\u0131nar","year":"2018","unstructured":"\u00c7\u0131nar SL, Kartal D, Pergel T, Borlu M. Effectiveness and safety of clonazepam, pregabalin, and alpha lipoic acid for the treatment of burning mouth syndrome. Erciyes Med J. 2018;40:35\u20138.","journal-title":"Erciyes Med J"},{"key":"2220_CR98","doi-asserted-by":"crossref","unstructured":"de Greef BTA, Merkies ISJ, Geerts M, Faber CG, Hoeijmakers JGJ. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study. Trials. 2016;17:306.","DOI":"10.1186\/s13063-016-1430-1"},{"key":"2220_CR99","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/brain\/awy329","volume":"142","author":"BTA de Greef","year":"2019","unstructured":"de Greef BTA, Hoeijmakers JG, Geerts M, Oakes M, Church TJ, Waxman SG, Dib-Hajj SD, Faber CG, Merkies IS. Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial. Brain. 2019;142:263\u201375.","journal-title":"Brain"},{"key":"2220_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10121022","volume":"10","author":"M Vecchio","year":"2020","unstructured":"Vecchio M, Chiaramonte R, Romano M, Pavone P, Musumeci G, Mauro GL. A systematic review of pharmacologic and rehabilitative treatment of small fiber neuropathies. Diagnostics. 2020;10: 1022.","journal-title":"Diagnostics"},{"key":"2220_CR101","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/mol.107.039867","volume":"73","author":"AC Errington","year":"2008","unstructured":"Errington AC, St\u00f6hr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2008;73:157\u201369.","journal-title":"Mol Pharmacol"},{"key":"2220_CR102","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1111\/odi.14966","volume":"30","author":"T Negamine","year":"2020","unstructured":"Negamine T. Amitriptyline at low dose for burning mouth syndrome. Oral Dis. 2020;30:4650\u20132.","journal-title":"Oral Dis"},{"key":"2220_CR103","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","volume":"25","author":"FP Bymaster","year":"2001","unstructured":"Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001;25:871\u201380.","journal-title":"Neuropsychopharmacology"},{"key":"2220_CR104","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2174\/0929867324666170712165042","volume":"25","author":"R Mandrioli","year":"2018","unstructured":"Mandrioli R, Protti M, Mercolini L. New-generation, non-SSRI antidepressants: therapeutic drug monitoring and pharmacological interactions. Part 1: SNRIs, SMSs, SARIs. Curr Med Chem. 2018;25:772\u201392.","journal-title":"Curr Med Chem"},{"key":"2220_CR105","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3389\/fpsyg.2019.01700","volume":"10","author":"Y Tan","year":"2019","unstructured":"Tan Y, Wu X, Chen J, Kong L, Qian Z. Structural and functional connectivity between the amygdala and orbital frontal cortex in burning mouth syndrome: an fMRI study. Front Psychol. 2019;10:1700.","journal-title":"Front Psychol"},{"key":"2220_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2818","volume":"37","author":"M Nakamura","year":"2022","unstructured":"Nakamura M, Yoshimi A, Mouri A, Tokura T, Kimura H, Kishi S, Miyauchi T, Iwamoto K, Ito M, Sato-Boku A, Ozaki N, Nabeshima T, Noda Y. Duloxetine attenuates pain in association with downregulation of platelet serotonin transporter in patients with burning mouth syndrome and atypical odontalgia. Hum Psychopharmacol. 2022;37: e2818.","journal-title":"Hum Psychopharmacol"},{"key":"2220_CR107","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.ijom.2017.03.032","volume":"46","author":"M Fenelon","year":"2017","unstructured":"Fenelon M, Quinque E, Arrive E, Catros S, Fricain JC. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study. Int J Oral Maxillofac Surg. 2017;46:1505\u201311.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2220_CR108","first-page":"505","volume":"9","author":"A Pakfetrat","year":"2019","unstructured":"Pakfetrat A, Talebi M, Dalirsani Z, Mohajeri A, Zamani R, Ghazi A. Evaluation of the effectiveness of crocin isolated from saffron in treatment of burning mouth syndrome: a randomized controlled trial. Avicenna J Phytomed. 2019;9:505\u201316.","journal-title":"Avicenna J Phytomed"},{"key":"2220_CR109","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/pm\/pnz120","volume":"21","author":"D Adamo","year":"2020","unstructured":"Adamo D, Pecoraro G, Aria M, Favia G, Mignogna MD. Vortioxetine in the treatment of mood disorders associated with burning mouth syndrome: results of an open-label, flexible-dose pilot study. Pain Med. 2020;21:185\u201394.","journal-title":"Pain Med"},{"key":"2220_CR110","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4088\/JCP.v63n0108","volume":"63","author":"G Maina","year":"2002","unstructured":"Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry. 2002;63:38\u201343.","journal-title":"J Clin Psychiatry"},{"key":"2220_CR111","first-page":"83","volume":"13","author":"T Tammiala-Salonen","year":"1999","unstructured":"Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain. 1999;13:83\u20138.","journal-title":"J Orofac Pain"},{"key":"2220_CR112","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/odi.13602","volume":"27","author":"D Adamo","year":"2021","unstructured":"Adamo D, Pecoraro G, Coppola N, Calabria E, Aria M, Mignogna M. Vortioxetine versus other antidepressants in the treatment of burning mouth syndrome: an open-label randomized trial. Oral Dis. 2021;27:1022\u201341.","journal-title":"Oral Dis"},{"key":"2220_CR113","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1526-4637.2010.01035.x","volume":"12","author":"MD Mignogna","year":"2011","unstructured":"Mignogna MD, Adamo D, Schiavone V, Ravel MG, Fortuna G. Burning mouth syndrome responsive to duloxetine: a case report. Pain Med. 2011;12:466\u20139.","journal-title":"Pain Med"},{"key":"2220_CR114","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1177\/0300060514527913","volume":"42","author":"YD Kim","year":"2014","unstructured":"Kim YD, Lee JH, Shim JH. Duloxetine in the treatment of burning mouth syndrome refractory to conventional treatment: a case report. J Int Med Res. 2014;42:879\u201383.","journal-title":"J Int Med Res"},{"key":"2220_CR115","first-page":"CD002779","volume":"11","author":"JM Zakrzewska","year":"2016","unstructured":"Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev. 2016;11:CD002779.","journal-title":"Cochrane Database Syst Rev"},{"key":"2220_CR116","doi-asserted-by":"crossref","unstructured":"Lebel A, Da Silva Vieira D, Boucher Y. Topical amitriptyline in burning mouth syndrome: a retrospective real-world evidence study. Headache. 2024;64: 1167\u201373.","DOI":"10.1111\/head.14818"},{"key":"2220_CR117","first-page":"167","volume":"4","author":"C Rodriguez-Cerdeira","year":"2012","unstructured":"Rodriguez-Cerdeira C, Sanchez-Blanco E. Treatment of burning mouth syndrome with amisulpride. J Clin Med Res. 2012;4:167\u201371.","journal-title":"J Clin Med Res"},{"key":"2220_CR118","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2147\/NDT.S94426","volume":"12","author":"Y Umezaki","year":"2016","unstructured":"Umezaki Y, Takenoshita M, Toyofuku A. Low-dose aripiprazole for refractory burning mouth syndrome. Neuropsychiatr Dis Treat. 2016;12:1229\u201331.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2220_CR119","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/pm\/pnw200","volume":"18","author":"M Takenoshita","year":"2017","unstructured":"Takenoshita M, Motomura H, Toyofuku A. Low-dose aripiprazole augmentation in amitriptyline-resistant burning mouth syndrome: results from two cases. Pain Med. 2017;18:814\u20135.","journal-title":"Pain Med"},{"key":"2220_CR120","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/WNF.0000000000000386","volume":"43","author":"\u00d6 Uzun","year":"2020","unstructured":"Uzun \u00d6, Bolu A. Low-dose aripiprazole augmentation in the treatment of burning mouth syndrome: a case report. Clin Neuropharmacol. 2020;43:92.","journal-title":"Clin Neuropharmacol"},{"key":"2220_CR121","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/odi.12386","volume":"22","author":"C Treldal","year":"2016","unstructured":"Treldal C, Jacobsen CB, Mogensen S, Rasmussen M, Jacobsen J, Petersen J, Lynge Pedersen AM, Andersen O. Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome. Oral Dis. 2016;22:123\u201331.","journal-title":"Oral Dis"},{"key":"2220_CR122","doi-asserted-by":"publisher","first-page":"e890","DOI":"10.4317\/medoral.17224","volume":"16","author":"J Silvestre-Rangil","year":"2011","unstructured":"Silvestre-Rangil J, Silvestre F-J, Tamarit-Santafe C, Bautista D. Burning mouth syndrome: correlation of treatment to clinical variables of the disease. Med Oral Patol Oral Cir Bucal. 2011;16:e890\u20134.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2220_CR123","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1079-2104(99)70010-7","volume":"88","author":"A Sardella","year":"1999","unstructured":"Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C, Carrassi A. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:683\u20136.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2220_CR124","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1749-6632.1998.tb10657.x","volume":"855","author":"BK Formaker","year":"1998","unstructured":"Formaker BK, Mott AE, Frank ME. The effects of topical anesthesia on oral burning in burning mouth syndrome. Ann NY Acad Sci. 1998;855:776\u201380.","journal-title":"Ann NY Acad Sci"},{"key":"2220_CR125","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/odi.13267","volume":"26","author":"C Treldal","year":"2020","unstructured":"Treldal C, Petersen J, Mogensen S, Therkildsen C, Jacobsen J, Andersen O, Pedersen AML. Characterization of burning mouth syndrome profiles based on response to a local anaesthetic lozenge. Oral Dis. 2020;26:656\u201369.","journal-title":"Oral Dis"},{"key":"2220_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6040082","volume":"6","author":"K Toljian","year":"2018","unstructured":"Toljian K, Vrooman B. Low-dose naltrexone (LDN)\u2014review of therapeutic utilization. Med Sci. 2018;6: 82.","journal-title":"Med Sci"},{"key":"2220_CR127","unstructured":"Singh D, Saadabadi A. Naltrexone [Updated 2023]. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2023. Accessed on 5 Aug 2023."},{"key":"2220_CR128","volume":"17","author":"KK Leiber","year":"2025","unstructured":"Leiber KK, Parker RW. Therapeutic uses and efficacy of low-dose naltrexone: a scoping review. Cureus. 2025;17: e81086.","journal-title":"Cureus"},{"key":"2220_CR129","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-020-00898-0","volume":"24","author":"PS Kim","year":"2020","unstructured":"Kim PS, Fishman MA. Low-dose naltrexone for chronic pain: update and systemic review. Curr Pain Headache Rep. 2020;24: 64.","journal-title":"Curr Pain Headache Rep"},{"key":"2220_CR130","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0087-21.2021","volume":"8","author":"MJ Metz","year":"2021","unstructured":"Metz MJ, Daimon CC, Hentges ST. Reported benefits of low-dose naltrexone appear to be independent of the endogenous opioid system involving proopiomelanocortin neurons and \u03b2-endorphin. eNeuro. 2021;8: ENEURO.0087-21.2021.","journal-title":"eNeuro"},{"key":"2220_CR131","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jad.2016.08.029","volume":"208","author":"D Mischoulon","year":"2017","unstructured":"Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. J Affect Disord. 2017;208:6\u201314.","journal-title":"J Affect Disord"},{"key":"2220_CR132","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/j.oooo.2022.04.048","volume":"135","author":"L Sangalli","year":"2023","unstructured":"Sangalli L, Miller CS. Low-dose naltrexone for treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;135:e83\u20138.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2220_CR133","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000001475","volume":"15","author":"DL Neuman","year":"2021","unstructured":"Neuman DL, Chadwick AL. Utilization of low-dose naltrexone for burning mouth syndrome: a case report. A&A Pract. 2021;15: e01475.","journal-title":"A&A Pract"},{"key":"2220_CR134","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2147\/JPR.S395457","volume":"16","author":"J Yang","year":"2023","unstructured":"Yang J, Shin KM, Do A, Bierle DM, Abu Dabrh AM, Yin Z, Bauer BA, Mohabbat AB. The safety and efficacy of low-dose naltrexone in patients with fibromyalgia: a systematic review. J Pain Res. 2023;16:1017\u201323.","journal-title":"J Pain Res"},{"key":"2220_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135248","author":"CL de Oliveira","year":"2020","unstructured":"de Oliveira CL, Medeiros LF, de Souza VS, Lopes BC, de Oliveira FF, Marques LX, da Silva Torres IL, de Souza A. Low-dose naltrexone reverses facial mechanical allodynia in a rat model of trigeminal neuralgia. Neurosci Lett. 2020. https:\/\/doi.org\/10.1016\/j.neulet.2020.135248.","journal-title":"Neurosci Lett"},{"key":"2220_CR136","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.yfrne.2006.09.003","volume":"27","author":"F Sohrabji","year":"2006","unstructured":"Sohrabji F, Lewis DK. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol. 2006;27:404\u201314.","journal-title":"Front Neuroendocrinol"},{"key":"2220_CR137","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jds.2021.06.007","volume":"17","author":"SH Seol","year":"2022","unstructured":"Seol SH, Chung G. Estrogen-dependent regulation of transient receptor potential vanilloid 1 (TRPV1) and P2X purinoceptor 3 (P2X3): implication in burning mouth syndrome. J Dent Sci. 2022;17:8\u201313.","journal-title":"J Dent Sci"},{"key":"2220_CR138","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1111\/joor.13831","volume":"51","author":"KG Brauwers","year":"2024","unstructured":"Brauwers KG, Bueno VM, Calcia TBB, Daroit NB. Sexual hormones changes in burning mouth syndrome: a systematic review. J Oral Rehabil. 2024;51:2475\u201383.","journal-title":"J Oral Rehabil"},{"key":"2220_CR139","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/dj8040111","volume":"8","author":"B Lon\u010dar-Brzak","year":"2020","unstructured":"Lon\u010dar-Brzak B, Vidranski V, Andabak-Rogulj A, Vidovi\u0107-Juras D, Todori\u0107-Laidlaw I, Gabri\u0107 D, \u0160krinjar I. Salivary hormones and quality of life in female postmenopausal burning mouth patients\u2014a pilot case\u2013control study. Dent J (Basel). 2020;8:111.","journal-title":"Dent J (Basel)"},{"key":"2220_CR140","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/0030-4220(92)90100-5","volume":"73","author":"A Forabosco","year":"1992","unstructured":"Forabosco A, Crischuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S, Botticelli A, Volpe A. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol. 1992;73:570\u20134.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2220_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-5122(91)90279-Y","volume":"13","author":"A Volpe","year":"1991","unstructured":"Volpe A, Lucenti V, Forabosco A. Oral discomfort and hormonal therapy in post menopause. Maturitus. 1991;13:1\u20135.","journal-title":"Maturitus."},{"key":"2220_CR142","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1067\/moe.2001.117452","volume":"92","author":"L Tarkkila","year":"2001","unstructured":"Tarkkila L, Linna M, Tiitinen A, Lindqvist C, Meurman JH. Oral symptoms at menopause\u2014the role of hormone replacement therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:276\u201380.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2220_CR143","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4158\/EP171828.PS","volume":"23","author":"RH Cobin","year":"2017","unstructured":"Cobin RH, Goodman NF. American Association of Clinical Endocrinologists and American College of Endocrinology Position statement on menopause\u20142017 update. Endocr Pract. 2017;23:869\u201380.","journal-title":"Endocr Pract"},{"key":"2220_CR144","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7326\/L16-0451","volume":"166","author":"DA Restivo","year":"2017","unstructured":"Restivo DA, Lauria G, Marchese-Ragona R, Vigneri R. Botulinum toxin for burning mouth syndrome. Ann Intern Med. 2017;166:762\u20133.","journal-title":"Ann Intern Med"},{"key":"2220_CR145","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0891-5849(95)00017-R","volume":"19","author":"L Packer","year":"1995","unstructured":"Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med. 1995;19:227\u201350.","journal-title":"Free Radic Biol Med"},{"key":"2220_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176878","volume":"980","author":"MI Fahmy","year":"2024","unstructured":"Fahmy MI, Khalaf SS, Elrayess RA. The neuroprotective effects of alpha lipoic acid in rotenone-induced Parkinson\u2019s disease in mice via activating PI3K\/AKT pathway and antagonizing related inflammatory cascades. Eur J Pharmacol. 2024;980: 176878.","journal-title":"Eur J Pharmacol"},{"key":"2220_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13101228","volume":"13","author":"F Superti","year":"2024","unstructured":"Superti F, Russo R. Alpha-lipoic acid: biological mechanisms and health benefits. Antioxidants. 2024;13: 1228.","journal-title":"Antioxidants"},{"key":"2220_CR148","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.jds.2024.11.017","volume":"20","author":"N Pinto-Pardo","year":"2025","unstructured":"Pinto-Pardo N, Rodriguez-Zaninovic MP. Redefining burning mouth syndrome: a nociplastic pain disorder? J Dent Sci. 2025;20:1382\u20133.","journal-title":"J Dent Sci"},{"key":"2220_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1186","volume":"6","author":"S Banik","year":"2023","unstructured":"Banik S, Ghosh A, Sato H, Onoue S. The efficacy of alpha-lipoic acid in the management of burning mouth syndrome: an updated systematic review of randomized controlled clinical trials. Health Sci Rep. 2023;6: e1186.","journal-title":"Health Sci Rep"},{"key":"2220_CR150","doi-asserted-by":"publisher","first-page":"323","DOI":"10.17245\/jdapm.2022.22.5.323","volume":"22","author":"J Christy","year":"2022","unstructured":"Christy J, Noorani S, Sy F, Al-Eryani K, Enciso R. Efficacy of alpha-lipoic acid in patients with burning mouth syndrome compared to that of placebo or other interventions: a systematic review with meta-analyses. J Dent Anesth Pain Med. 2022;22:323\u201338.","journal-title":"J Dent Anesth Pain Med"},{"key":"2220_CR151","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ejpain.2008.06.004","volume":"13","author":"M Carbone","year":"2009","unstructured":"Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain. 2009;13:492\u20136.","journal-title":"Eur J Pain"},{"key":"2220_CR152","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1365-2842.2008.01914.x","volume":"36","author":"P L\u00f3pez-Jornet","year":"2009","unstructured":"L\u00f3pez-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil. 2009;36:52\u20137.","journal-title":"J Oral Rehabil"},{"key":"2220_CR153","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-0714.2008.00735.x","volume":"38","author":"DR Cavalcanti","year":"2009","unstructured":"Cavalcanti DR, da Silveira FF. Alpha lipoic acid in burning mouth syndrome\u2014a randomized double-blind placebo-controlled trial. J Oral Pathol Med. 2009;38:254\u201361.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR154","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1600-0714.2008.00663.x","volume":"37","author":"A Sardella","year":"2008","unstructured":"Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A. Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study. J Oral Pathol Med. 2008;37:395\u2013401.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR155","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/joor.12147","volume":"41","author":"P Cano-Carrillo","year":"2014","unstructured":"Cano-Carrillo P, Pons-Fuster A, L\u00f3pez-Jornet P. Efficacy of lycopene-enriched virgin olive oil for treating burning mouth syndrome: a double-blind randomised. J Oral Rehabil. 2014;41:296\u2013305.","journal-title":"J Oral Rehabil"},{"key":"2220_CR156","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1590\/0004-282X20130218","volume":"72","author":"LA Silva","year":"2014","unstructured":"Silva LA, Siqueira JT, Teixeira MJ, Siqueira SR. The role of xerostomia in burning mouth syndrome: a case\u2013control study. Arq Neuropsiquiatr. 2014;72:91\u20138.","journal-title":"Arq Neuropsiquiatr"},{"key":"2220_CR157","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.oooo.2011.09.005","volume":"113","author":"JC Spanemberg","year":"2012","unstructured":"Spanemberg JC, Cherubini K, de Figueiredo MA, Gomes AP, Campos MM, Salum FG. Effect of an herbal compound for treatment of burning mouth syndrome: randomized, controlled, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:373\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2220_CR158","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902023e21748","author":"T Nosratzehi","year":"2023","unstructured":"Nosratzehi T, Payandeh A, Arbab K. Evaluation of the effect of melatonin in patients with burning mouth syndrome: a double-blind placebo-controlled randomized clinical trial. Braz J Pharm Sci. 2023. https:\/\/doi.org\/10.1590\/s2175-97902023e21748.","journal-title":"Braz J Pharm Sci"},{"key":"2220_CR159","doi-asserted-by":"publisher","first-page":"178","DOI":"10.11607\/ofph.1913","volume":"32","author":"EM Varoni","year":"2018","unstructured":"Varoni EM, Lo Faro AF, Lodi G, Carrassi A, Iriti M, Sardella A. Melatonin treatment in patients with burning mouth syndrome: a triple-blind, placebo-controlled, crossover randomized clinical trial. J Oral Facial Pain Headache. 2018;32:178\u201388.","journal-title":"J Oral Facial Pain Headache"},{"key":"2220_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092516","volume":"11","author":"C Castillo-Felipe","year":"2022","unstructured":"Castillo-Felipe C, Tvarjonaviciute A, L\u00f3pez-Arjona M, Pardo-Marin L, Pons-Fuster E, L\u00f3pez-Jornet P. Response to treatment with melatonin and clonazepam versus placebo in patients with burning mouth syndrome. J Clin Med. 2022;11: 2516.","journal-title":"J Clin Med"},{"key":"2220_CR161","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13030-021-00221-2","volume":"15","author":"H Hato","year":"2021","unstructured":"Hato H, Sakata K-I, Sato J, Asaka T, Ohga N, Yamazaki Y, Kitagawa Y. Efficacy of rikkosan for primary burning mouth syndrome: a retrospective study. BioPsychoSocial Med. 2021;15:19.","journal-title":"BioPsychoSocial Med"},{"key":"2220_CR162","first-page":"1013","volume":"12","author":"T Itagaki","year":"2024","unstructured":"Itagaki T, Nakamura K, Tanabe T, Shimura T, Nakai Y, Sakata KI, Sato J, Kitagawa Y. Rikkosan\u2019s short-term analgesic effect on burning mouth syndrome: a single-arm cohort study. Biomedicines. 2024;12:1013.","journal-title":"BIomed"},{"key":"2220_CR163","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/oral4030031","volume":"4","author":"R Aouididi","year":"2024","unstructured":"Aouididi R, Qutieshat A. Combination of turmeric and vitamin B6 in burning mouth syndrome: a retrospective single-arm study. Oral. 2024;4:376\u201385.","journal-title":"Oral"},{"key":"2220_CR164","first-page":"e499","volume":"10","author":"AM Milani","year":"2018","unstructured":"Milani AM, Macedo CL, Bello MD, Klein-J\u00fanior CA, Dos Santos RB. A successful approach to control burning mouth syndrome using Matricaria recutita and cognitive therapy. J Clin Exp Dent. 2018;10:e499\u2013501.","journal-title":"J Clin Exp Dent"},{"key":"2220_CR165","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/jop.12412","volume":"45","author":"S Valenzuela","year":"2016","unstructured":"Valenzuela S, Pons-Fuster A, L\u00f3pez-Jornet P. Effect of a 2% topical chamomile application for treating burning mouth syndrome: a controlled clinical trial. J Oral Pathol Med. 2016;45:528\u201333.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR166","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/joor.13957","volume":"52","author":"C Wu","year":"2025","unstructured":"Wu C, Yuan P, Qiu X, Liu D, Xu Y, Xiao Y, Zhou S, Zhang Z, Cai S, Ding W, Xu X, Hou F, Jiang L. Short-term dietary caffeine intake for alleviating symptoms of burning mouth syndrome: a randomised controlled comparison with alpha-lipoic acid. J Oral Rehab. 2025;52:969\u201378.","journal-title":"J Oral Rehab"},{"key":"2220_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57040391","volume":"57","author":"V Jankovskis","year":"2021","unstructured":"Jankovskis V, Selga G. Vitamin B and zinc supplements and capsaicin oral rinse treatment options for burning mouth syndrome. Medicina (Kaunas). 2021;57: 391.","journal-title":"Medicina (Kaunas)"},{"key":"2220_CR168","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jop.12043","volume":"42","author":"A Sun","year":"2013","unstructured":"Sun A, Lin HP, Wang YP, Chen HM, Cheng SJ, Chiang CP. Significant reduction of serum homocysteine level and oral symptoms after different vitamin-supplement treatments in patients with burning mouth syndrome. J Oral Pathol Med. 2013;42:474\u20139.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR169","first-page":"39","volume":"12","author":"D Chirchiglia","year":"2019","unstructured":"Chirchiglia D, Chirchiglia P, Marotta R, Gallelli L. Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome. Int Med Case Rep J. 2019;12:39\u201342.","journal-title":"Int Med Case Rep J"},{"key":"2220_CR170","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1051\/mbcb\/2020032","volume":"26","author":"PA Lecor","year":"2020","unstructured":"Lecor PA, Toure B, Moreau N, Braud A, Dieb W, Boucher Y. Could methylene blue be used to manage burning mouth syndrome? A pilot case series. J Oral Med Oral Surg. 2020;26:35.","journal-title":"J Oral Med Oral Surg"},{"key":"2220_CR171","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/joor.13536","volume":"50","author":"AL Porporatti","year":"2023","unstructured":"Porporatti AL, Schroder \u00c2G, Lebel A, Moreau N, Misery L, Alajbeg I, Braud A, Boucher Y. Is burning mouth syndrome associated with stress? A meta-analysis. J Oral Rehab. 2023;50:1279\u2013315.","journal-title":"J Oral Rehab"},{"key":"2220_CR172","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jpsychores.2015.02.006","volume":"78","author":"T Tokura","year":"2015","unstructured":"Tokura T, Kimura H, Ito M, Nagashima W, Sato N, Kimura Y, Arao M, Aleksic B, Yoshida K, Kurita K, Ozaki N. Temperament and character profiles of patients with burning mouth syndrome. J Psychosom Res. 2015;78:495\u20138.","journal-title":"J Psychosom Res"},{"key":"2220_CR173","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/jamaoto.2020.0526","volume":"146","author":"JY Kim","year":"2020","unstructured":"Kim JY, Kim YS, Ko I, Kim DK. Association between burning mouth syndrome and the development of depression, anxiety, dementia, and Parkinson disease. JAMA Otolaryngol Head Neck Surg. 2020;146:561\u20139.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2220_CR174","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1600-0714.1995.tb01169.x","volume":"24","author":"J Bergdahl","year":"1995","unstructured":"Bergdahl J, Annaroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med. 1995;24:213\u20135.","journal-title":"J Oral Pathol Med"},{"key":"2220_CR175","first-page":"293","volume":"17","author":"JM Zakrzewska","year":"2003","unstructured":"Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome: a systematic review. J Orofac Pain. 2003;17:293\u2013300.","journal-title":"J Orofac Pain"},{"key":"2220_CR176","doi-asserted-by":"publisher","first-page":"175","DOI":"10.11607\/ofph.2868","volume":"35","author":"M Cabras","year":"2021","unstructured":"Cabras M, Gambino A, Broccoletti R, De Paola S, Sciascia S, Arduino PG. Effectiveness of nonpharmacologic treatments of burning mouth syndrome: a systematic review. J Oral Facial Pain Headache. 2021;35:175\u201398.","journal-title":"J Oral Facial Pain Headache"},{"key":"2220_CR177","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.oooo.2024.07.007","volume":"138","author":"CB Calderipe","year":"2024","unstructured":"Calderipe CB, Kirschnick LB, Esteves-Pereira TC, Dos Santos ES, Vasconcelos ACU, Lopes MA, Treister NS, Santos-Silva AR. Local anesthesia nerve block for managing burning mouth syndrome: a scoping review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2024;138:619\u201325.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2220_CR178","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pain.2009.11.016","volume":"149","author":"C Gr\u00e9meau-Richard","year":"2010","unstructured":"Gr\u00e9meau-Richard C, Dubray C, Aublet-Cuvelier B, Ughetto S, Woda A. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain. 2010;149:27\u201332.","journal-title":"Pain"},{"key":"2220_CR179","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/s12903-023-03441-w","volume":"23","author":"C Lu","year":"2023","unstructured":"Lu C, Yanc C, Li X, Du G, Zhou X, Luo W, Du Q, Tang G. Effects of low-level laser therapy on burning pain and quality of life in patients with burning mouth syndrome: a systematic review and meta-analysis. BMC Oral Health. 2023;23:734.","journal-title":"BMC Oral Health"},{"key":"2220_CR180","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/joor.13931","volume":"52","author":"MR Okuhara","year":"2025","unstructured":"Okuhara MR, Trevisani VFM, Macedo CR. Effects of photobiomodulation on burning mouth syndrome: a systematic review and meta-analysis. J Oral Rehabil. 2025;52:540\u201353.","journal-title":"J Oral Rehabil"},{"key":"2220_CR181","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10103-020-03109-9","volume":"36","author":"W Zhang","year":"2021","unstructured":"Zhang W, Hu L, Zhao W, Yan Z. Effectiveness of photobiomodulation in the treatment of primary burning mouth syndrome\u2014a systematic review and meta-analysis. Lasers Med Sci. 2021;36:239\u201348.","journal-title":"Lasers Med Sci"},{"key":"2220_CR182","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pdpdt.2016.11.017","volume":"17","author":"SA Al-Maweri","year":"2017","unstructured":"Al-Maweri SA, Javed F, Kalakonda B, AlAizari NA, Al-Soneidar W, Al-Akwa A. Efficacy of low level laser therapy in the treatment of burning mouth syndrome: a systematic review. Photodiagn Photodyn Ther. 2017;17:188\u201393.","journal-title":"Photodiagn Photodyn Ther"},{"key":"2220_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111838","volume":"13","author":"R Hanna","year":"2021","unstructured":"Hanna R, Dalvi S, Bensadoun RJ, Raber-Durlacher JE, Benedicenti S. Role of photobiomodulation therapy in neurological primary burning mouth syndrome. A systematic review and meta-analysis of human randomised controlled clinical trials. Pharmaceutics. 2021;13: 1838.","journal-title":"Pharmaceutics"},{"key":"2220_CR184","first-page":"17","volume":"38","author":"M Khemiss","year":"2024","unstructured":"Khemiss M, Dammak N, Lajili O, Yacoub S, Ben KM. Efficacy of laser therapy on primary burning mouth syndrome: a systematic review. J Oral Facial Pain Headache. 2024;38:17\u201331.","journal-title":"J Oral Facial Pain Headache"},{"key":"2220_CR185","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.4317\/medoral.24144","volume":"26","author":"A Matos","year":"2021","unstructured":"Matos A, Silva PU, Paranhos LR, Santana IT, Matos FR. Efficacy of the laser at low intensity on primary burning oral syndrome: a systematic review. Med Oral Patol Oral Cir Bucal. 2021;26:e216\u201325.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2220_CR186","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12916-025-04015-z","volume":"23","author":"C Lu","year":"2025","unstructured":"Lu C, Zhou X, Yang C, Jiang X, Li X, Huang Z, Du Q, Tang G. Efficacy and safety of photobiomodulation combined with oral cryotherapy on oral mucosa pain in patients with burning mouth syndrome: a multi-institutional, randomized, controlled trial. BMC Med. 2025;23:196.","journal-title":"BMC Med"},{"key":"2220_CR187","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.brs.2015.10.005","volume":"9","author":"Y Umezaki","year":"2016","unstructured":"Umezaki Y, Badran BW, DeVries WH, Moss J, Gonzales T, George MS. The efficacy of daily prefrontal repetitive transcranial magnetic stimulation (rTMS) for burning mouth syndrome (BMS): a randomized controlled single-blind study. Brain Stimul. 2016;9:234\u201342.","journal-title":"Brain Stimul"},{"key":"2220_CR188","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ijom.2015.04.008","volume":"44","author":"Y Umezaki","year":"2015","unstructured":"Umezaki Y, Badran BW, Gonzales TS, George MS. Daily left prefrontal repetitive transcranial magnetic stimulation for medication-resistant burning mouth syndrome. Int J Oral Maxillofac Surg. 2015;44:1048\u201351.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2220_CR189","first-page":"695","volume":"43","author":"Z Yan","year":"2012","unstructured":"Yan Z, Ding N, Hua H. A systematic review of acupuncture or acupoint injection for management of burning mouth syndrome. Quintessence Int. 2012;43:695\u2013701.","journal-title":"Quintessence Int"},{"key":"2220_CR190","doi-asserted-by":"crossref","unstructured":"Scardina G, Ruggieri A, Provenzano F, Messin P. Burning mouth syndrome: is acupuncture a therapeutic possibility? Br Dent J. 2010;209:E2.","DOI":"10.1038\/sj.bdj.2010.582"},{"key":"2220_CR191","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1601-0825.2010.01737.x","volume":"17","author":"P L\u00f3pez-Jornet","year":"2011","unstructured":"L\u00f3pez-Jornet P, Camacho-Alonso F, Andujar-Mateos P. A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome. Oral Dis. 2011;17:277\u201382.","journal-title":"Oral Dis"},{"key":"2220_CR192","doi-asserted-by":"publisher","first-page":"8999","DOI":"10.3390\/ijerph19158999","volume":"19","author":"J Zborowski","year":"2022","unstructured":"Zborowski J, Konopka T. Comparison of clonazepam and tongue protector in the treatment of burning mouth syndrome. Int J Environ Res Public Health. 2022;19:8999.","journal-title":"Int J Environ Res Public Health"},{"key":"2220_CR193","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/head.12338","volume":"54","author":"Y Kim","year":"2014","unstructured":"Kim Y, Kim HI, Kho HS. Characteristics of men and premenopausal women with burning mouth symptoms: a case\u2013control study. Headache. 2014;54:888\u201398.","journal-title":"Headache"},{"key":"2220_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53074-4","volume":"14","author":"E Calabria","year":"2024","unstructured":"Calabria E, Canfora F, Leuci S, Coppola N, Pecoraro G, Giudice A, Antonelli A, Aria M, D\u2019Aniello L, Mignogna MD, Adamo D. Gender differences in pain perception among burning mouth syndrome patients: a cross-sectional study of 242 men and 242 women. Sci Rep. 2024;14: 3340.","journal-title":"Sci Rep"},{"key":"2220_CR195","volume":"2","author":"R Alsabbagh","year":"2022","unstructured":"Alsabbagh R, Ouanounou A. Burning mouth syndrome: etiology, clinical presentations, and treatment alternatives. Dent Rev. 2022;2: 100036.","journal-title":"Dent Rev"},{"key":"2220_CR196","doi-asserted-by":"publisher","first-page":"174480691668679","DOI":"10.1177\/1744806916686796","volume":"13","author":"EH Ji","year":"2017","unstructured":"Ji EH, Diep C, Liu T, Li H, Merrill R, Messadi D, Hu S. Potential protein biomarkers for burning mouth syndrome discovered by quantitative proteomics. Mol Pain. 2017;13:1744806916686796.","journal-title":"Mol Pain"},{"key":"2220_CR197","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/jcm9040929","volume":"9","author":"P Lopez-Jornet","year":"2020","unstructured":"Lopez-Jornet P, Felipe CC, Pardo-Marin L, Ceron JJ, Pons-Fuster E, Tvarijonaviciute A. Salivary biomarkers and their correlation with pain and stress in patients with burning mouth syndrome. J Clin Med. 2020;9:929.","journal-title":"J Clin Med"},{"key":"2220_CR198","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpain.2003.09.002","volume":"5","author":"RM Nagler","year":"2004","unstructured":"Nagler RM, Hershkovich O. Sialochemical and gustatory analysis in patients with oral sensory complaints. J Pain. 2004;5:56\u201363.","journal-title":"J Pain"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-025-02220-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-025-02220-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-025-02220-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:04:08Z","timestamp":1788339848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-025-02220-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":198,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s40265-025-02220-x","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"24 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare they have no conflicts of interest that might be relevant to the contents of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent (participation and publication)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":4,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualization: L.S.; Data collection: L.S., E.E.; Supervision: C.S.M.; Initial draft: L.S., J.M.K., S.M.; Final manuscript: L.S., J.M.K., S.M., C.S.M. All authors reviewed and approved the final manuscript.","order":6,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}